Drug agency Lupin on Wednesday launched a certified generic model of Antara (Fenoflbrate) capsules in US.
The corporate has launched generic model of Antara (Fenofibrate) capsules, within the strengths of 30 mg and 90 mg within the US, Lupin stated in a regulatory submitting.
The product is a generic model of the Lupin Atlantis Holdings, S A Company’s Antara capsules.
In response to IQVIA MAT September 2021 information, Fenofibrate capsules had estimated annual gross sales of $7 million within the US, Lupin stated.
“Fenofibrate Capsules are indicated as adjunctive remedy to weight loss plan to cut back elevated low-density lipoprotein ldl cholesterol, whole ldl cholesterol, triglycerides and apolipoprotein B , and to extend high-density lipoprotein ldl cholesterol in grownup sufferers with main hypercholesterolemia,” it added.
Shares of Lupin Ltd closed at ₹934.75 per scrip on BSE, up 0.44 % from its earlier shut.
Supply: Live Mint